Now the dust has settled over immune checkpoint blockade in metastatic prostate cancer
- PMID: 29992258
- DOI: 10.1093/annonc/mdy239
Now the dust has settled over immune checkpoint blockade in metastatic prostate cancer
Comment on
-
Pembrolizumab for advanced prostate adenocarcinoma: findings of the KEYNOTE-028 study.Ann Oncol. 2018 Aug 1;29(8):1807-1813. doi: 10.1093/annonc/mdy232. Ann Oncol. 2018. PMID: 29992241
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
